| Target Price | ¥42,840.00 |
| Price | ¥34,260.00 |
| Potential |
25.04%
register free of charge
|
| Number of Estimates | 26 |
|
26 Analysts have issued a price target Advantest 2027 .
The average Advantest target price is ¥42,840.00.
This is
25.04%
register free of charge
¥57,960.00
69.18%
register free of charge
¥21,243.30
37.99%
register free of charge
|
|
| A rating was issued by 28 analysts: 24 Analysts recommend Advantest to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Advantest stock has an average upside potential 2027 of
25.04%
register free of charge
|
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Billion ¥ | 1,128.61 | 1,725.25 |
| 44.75% | 52.86% | |
| EBITDA Margin | 45.63% | 51.78% |
| 32.72% | 13.48% | |
| Net Margin | 33.26% | 37.80% |
| 60.89% | 13.66% |
28 Analysts have issued a sales forecast Advantest 2027 . The average Advantest sales estimate is
This results in the following potential growth metrics:
18 Analysts have issued an Advantest EBITDA forecast 2027. The average Advantest EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
27 Advantest Analysts have issued a net profit forecast 2027. The average Advantest net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share ¥ | 513.30 | 900.74 |
| 135.45% | 75.48% | |
| P/E | 37.65 | |
| EV/Sales | 13.46 |
27 Analysts have issued a Advantest forecast for earnings per share. The average Advantest EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


